Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Trends & Forecasts

The Battle for the Future of American Healthcare

| James Strachan

Both candidates for the US presidency are advocating policies that would create a new pricing environment for pharma companies – but we’ve been here before. With regard to the Affordable Care Act, however, the election could prove a real turning point.

Business & Regulation Business Practice

Harnessing Dark Data

| Graeme Dennis

The pharma industry creates significant amounts of data – so why is most of it hoarded and never made accessible?

Business & Regulation Business Practice

Crisis Point

| Maryam Mahdi

The COVID-19 pandemic has caused worldwide disruption, but how has the it affected African pharma?

Register to personalize your newsfeed

Create Account

Latest Articles

Discovery & Development Drug Discovery

The Gut Response

| Maryam Mahdi

In what ways can the microbiome interact with oral medicines?

Business & Regulation Quality & Compliance

A Brave New World of Quality

| David Jones

QC must evolve to meet progress in biopharmaceutical manufacturing.

Business & Regulation Business Practice

Stemming the Brain Drain

| Kelly Chibale

What can African nations do to retain the talent necessary for building pharmaceutical infrastructure?

Business & Regulation Business Practice

Why the African Medicines Agency’s Hour Has Arrived

| Sarah Adam, Cyntia Genolet

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?

Manufacture Advanced Medicine

Serving a Rising Power

| Sponsored by GenScript

The gene and cell therapy market is growing, but does it have the CDMO support needed to maintain its upward trajectory?

Manufacture Vaccines

Success at Speed Part 6: Logistics and Global Availability

| Piergiuseppe Nestola, Amélie Boulais

A vaccine must be able to reach patients who need it. Reliable partners and procedures are a must.

Manufacture Advanced Medicine

A Living Elixir?

| James Strachan

Introducing the fourth therapeutic class: live biotherapeutics – microorganisms isolated from the human gut with the potential to treat many diseases.

Manufacture Vaccines

Success at Speed Part 5: Reducing Costs

| Amélie Boulais, Piergiuseppe Nestola

Global access to the vaccine is essential to provide protection against the virus. A big hurdle to accessibility will likely be price.

Business & Regulation Business Practice

Brexit Trading Unknowns

| Nik Kotecha

Is your business prepared for Brexit? Here’s some advice from Nik Kotecha.

Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Sutton

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

All Articles

Upcoming Events


Extractables and Leachables USA 2020

Bethesda, MD, USA

Smithers’ 9th annual Extractables and Leachables USA conference is returning to Bethesda, MD,  October 26-28, 2020. This...

Cell & Gene Therapy USA

Virtual event

Join 2000+ cell and gene commercial leaders for this free conference and get treatments to patients faster.


2020 ISPE Annual Meeting & Expo: Driving the Future of Pharma

Virtual event

The 2020 #ISPE Annual Meeting & Expo is an immersive interactive event for the global pharma community. Join your...

All Events

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine